Abstract
Non-insulin-dependent diabetes mellitus (NIDDM), also called type 2 diabetes mellitus, is a common metabolic disorder that afflicts 2%–5% of the adult population of most Western countries, with, however, wide international variation (King et al. 1993). Furthermore, NIDDM is often undiagnosed even in the Western countries (Hortulanus-Beck et al. 1990), and numerous data indicate that undiagnosed NIDDM is not a benign condition (Harris 1993). Certainly, NIDDM is a leading cause of disability and death in developed and developing nations (Songer 1992).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O (1993) Amino acid polymorphism in insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342:828–832
Arner P, Pollare T, Lithell H (1991) Different aetiologies of Type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects. Diabetologia 34:483–487
Bailey CJ, Flatt PR (1990) New antidiabetic drugs. Smith-Gordon, London
Banerji MA, Lebovitz HE (1989) Insulin-sensitive and insulin-resistant variants in NIDDM. Diabetes 38:784–792
Barnett AH, Eff C, Leslie RDG, Pyke DA (1981) Diabetes in identical twins: a study of 200 pairs. Diabetologia 20:87–93
Baron AD, Kolterman OG, Bell J, Mandarino LJ, Olefsky JM (1985) Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest 76: 1782–1788
Beck-Nielsen H, Hother-Nielsen O (1988) Insulin resistance. Diabetes Ann 4: 565–591
Beck-Nielsen H, Vaag A, Damsbo P, Handberg A, Hother Nielsen O, Henriksen JE, Thye-Ronn P (1992) Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care 15:418–429
Bell GI (1991) Lilly lecture 1990. Molecular defects in diabetes mellitus. Diabetes 40:413–422
Bergman RN, Steil GM, Bradley DC, Watanabe RM (1992) Modeling of insulin action in vivo. Annu Rev Physiol 54:861–883
Björntorp P (1988) Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 4:615–622
Björntorp P (1990) Obesity and diabetes. In: Alberti KGMM, Krall LP (eds) The diabetes annual/5. Elsevier, Amsterdam, pp 373–395
Bogardus C, Lillioja A, Stone K, Mott D (1984) Correlation of muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 73:1185–1190
Bonora E, Zavaroni I, Bruschi F, Alpi O, Pezzarossa A, Guerra L, Dall’Aglio E, Coscelli C, Butturini U (1984) Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism? J Clin Endocrinol Metab 59:1121–1127
Bray GA (1990) Obesity and diabetes. Acta Diabetol Lat 27:81–88
Bressler R, Johnson D (1992) New pharmacological approaches to therapy of NIDDM. Diabetes Care 15:792–805
Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL, Porte D (1976) Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 46:222–229
Butler PC, Kryshak EJ, Schwenk WF, Haymond MW, Rizza RA (1990) Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans: assessment in absence of artifact introduced by tritiated nonglucose contaminants. Diabetes 39:217–225
Campbell PJ, Carlson MG (1993) Impact of obesity on insulin action in NIDDM. Diabetes 42:405–410
Campbell PJ, Mandarino LJ, Gerich JE (1988) Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 37:15–21
Capaldo B, Napoli R, Di Bonito P, Albano G, Sacca L (1990) Glucose and gluconeogenic substrate exchange by the forearm skeletal muscle in hyperglycemic and insulin-treated type II diabetic patients. J Clin Endocrinol Metab 71: 1220–1223
Caro JF, Dohm LG, Pories WJ, Sinha MK (1989) Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type 2 diabetes. Diabetes Metab Rev 5:665–689
Castillo MJ, Scheen AJ, Jandrain B, Lefèbvre PJ (1994a) Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesity. Int J Obes 18:47–53
Castillo MJ, Scheen AJ, Letiexhe MR, Lefèbvre PJ (1994b) How to measure insulin clearance. Diabetes Metab Rev 10:119–150
Cerasi E (1988) Insulin secretion in diabetes mellitus. In: Lefèbvre PJ, Pipeleers DG (eds) The pathology of the endocrine pancreas in diabetes. Springer, Berlin Heidelberg New York, pp 191–218
Clark A (1992) Islet amyloid: an enigma of type 2 diabetes. Diabetes Metab Rev 8:117–132
Consoli A (1992) Role of liver in pathophysiology of NIDDM. Diabetes Care 15:430–441
Consoli A, Nurjhan N, Capani F, Gerich J (1989) Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38: 550–557
Consoli A, Nurjhan N, Reilly JJ Jr, Bier DM, Gerich JE (1990) Mechanism of increased gluconeogenesis in non-insulin dependent diabetes mellitus: role of alterations in systemic, hepatic and muscle lactate and alanine metabolism. J Clin Invest 86:2034–2045
Cox NJ, Xiang K-S, Fajans SS, Bell GI (1992) Mapping diabetes-susceptibility genes: lessons learned from search for DNA marker for maturity-onset-diabetes of the young. Diabetes 41:401–407
DeFronzo RA (1988) The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667–687
DeFronzo RA, Ferrannini E (1987) Regulation of hepatic glucose metabolism in humans. Diabetes Metab Rev 3:415–459
DeFronzo RA, Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173–194
DeFronzo RA, Ferrannini E, Koivisto V (1983) New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am J Med 75:52–81
DeFronzo R, Gunnarsson R, Bjorkman O, Olsson M, Wahren J (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent (type II) diabetes mellitus. J Clin Invest 76:146–155
DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318–368
DelPrato S, Bonadonna RC, Bonora E, Guli G, Solini A, Shank M, DeFronzo RA (1993) Characterization of cellular defects of insulin action in type 2 (noninsulin-dependent) diabetes mellitus. J Clin Invest 91:484–494
Dinneen S, Gerich J, Rizza R (1992) Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 327:707–713
Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L (1989) Early metabolic defects in persons at risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337–343
Eriksson J, Koranyi L, Bourey R, Schalin-Jantti C, Widen E, Mueckler M, Permutt AM, Groop LC (1992) Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle. Diabetologia 35:143–147
Eschwège E, Mehnert H, Reaven G, Vigneri R (eds) (1991) NIDD today. Diabete Metab 17:75–254
Fajans SS (1986) Heterogeneity of insulin secretion in type II diabetes. Diabetes Metab Rev 2:347–361
Felber JP, Golay A, Felley C, Jéquier E (1988) Regulation of glucose storage in obesity and diabetes: metabolic aspects. Diabetes Metab Rev 4:691–700
Felber JP, Acheson KJ, Tappy L (1993a) From obesity to diabetes. Wiley, Chichester
Felber JP, Haesler E, Jéquier E (1993b) Metabolic origin of insulin resistance in obesity with and without Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:1221–1229
Ferner RE, Alberti KGMM (1986) Why is there still disagreement over insulin secretion in non-insulin-dependent diabetes? Diabet Med 3:13–17
Ferrannini E, Cobelli C (1987) The kinetics of insulin in man. Diabetes Metab Rev 3:335–363, 365–397
Ferrannini E, Groop LC (1989) Hepatic glucose production in insulin-resistant states. Diabetes Metab Rev 5:711–725
Foley JE (1992) Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus. Diabetes Care 15:773–784
Froguel Ph, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa Ph, Permutt MA, Beckmann JS, Bell GI, Cohen D (1993) Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328:697–702
Ganrot PO (1993) Insulin resistance syndrome: possible key role of blood flow in resting muscle. Diabetologia 36:876–879
Garvey WT (1989) Insulin resistance and noninsulin-dependent diabetes mellitus: which horse is pulling the cart? Diabetes Metab Rev 5:727–742
Garvey WT (1992) Glucose transport and NIDDM. Diabetes Care 15:396–417
Garvey WT, Kolterman OG (1988) Correlation of in vivo and in vitro actions of insulin in obesity and noninsulin-dependent diabetes mellitus: role of the glucose transport system. Diabetes Metab Rev 4:543–569
Garvey TW, Revers RR, Kolterman OG, Rubenstein AH, Olefsky JM (1985) Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus. J Clin Endocrinol Metab 60:559–568
Gerich JE (1988) Role of insulin resistance in the pathogenesis of Type 2 (noninsulin-dependent) diabetes mellitus. Bailliere’s Clin Endocrinol Metab 2: 307–326
Gerich JE (1991) Is muscle the major site of insulin resistance in Type 2 (non-insulin-dependent) diabetes mellitus? Diabetologia 34:607–610
Gerich JE (1993) Control of glycaemia. Bailliere’s Clin Endocrinol Metab 7:551–586
Giugliano D, Torella R, Scheen AJ, Lefèbvre PJ, D’Onofrio F (1988) Prostaglandines, sécrétion d’insuline et diabète sucré. Diabete Metab 14:721–727
Golay A, Felber JP, Jéquier E, DeFronzo RA, Ferrannini E (1988) Metabolic basis of obesity and noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 4:727–747
Granner DK, O’Brien RM (1992) Molecular physiology and genetics of NIDDM. Importance of metabolic staging. Diabetes Care 15:369–395
Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: evidence for multiple sites of insulin resistance. J Clin Invest 84:205–213
Groop LC, Kankuri M, Schalin-Jantti C, Ekstrand A, Nikula-Ijas P, Widen E, Kuismanen E, Eriksson J, Franssila-Kallunki A, Saloranta C, Koskimies S (1993a) Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl Med 328:10–14
Groop LC, Widen E, Ferrannini E (1993b) Insulin resistance and insulin deficiency in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 36:1326–1331
Haffner SM, Stern MP, Watanabe RN, Bergman RN (1992) Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans. Eur J Clin Invest 22:147–153
Hales CN, Barker DJP (1992) Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 35:595–601
Hamman RF (1992) Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 8:287–338
Häring HU, Mehnert H (1993) Pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle. Diabetologia 36:176–182
Harris MI (1993) Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16:642–655
Hitman GA, McCarthy MI (1991) Genetics of non-insulin dependent diabetes mellitus. Bailliere’s Clin Endocrinol Metab 5:455–476
Hortulanus-Beck D, Lefèbvre PJ, Jeanjean MF (1990) Le diabète dans la province belge de Luxembourg: Fréquence, importance de l’épreuve de surcharge glucosée orale et d’une glycémie à jeun discrètement accrue. Diabete Metab 16:311–317
Hother-Nielsen O, Beck-Nielsen H (1990) On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia 33:603–610
Jansson P-AE, Fowelin JP, Von Schenck HP, Smith UP, Lönnroth PN (1993) Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Importance of the endothelial barrier for insulin. Diabetes 42:1469–1473
Johnson KH, O’Brien TD, Betsholtz C, Westermark P (1989) Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus. N Engl J Med 321:513–518
Kahn CR (1978) In:sulin resistance, insulin sensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 27:1893–1902
Kahn CR, Folli F (1993) Molecular determinants of insulin action. Horm Res [Suppl 3]:93–101
Karam JH, Grodsky GM, Forsham PH (1963) Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 12:197–204
Kelley DE, Mokan M, Mandarino LJ (1992) Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 41:698–706
Kelley DE, Mokan M, Mandarino LJ (1993) Metabolic pathways of glucose in skeletal muscle of lean NIDDM. Diabetes Care 16:1158–1166
King GL, Johnson SM (1985) Receptor-mediated transport of insulin across endothelial cells. Science 227:1583–1586
King H, Rewers M, WHO Ad Hoc Diabetes Reporting Group (1993) Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance. Diabetes Care 16:157–177
Kissebah AH, Peiris AN (1989) Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 5:83–109
Klip A, Paquet MR (1990) Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 13:228–243
Kolterman O, Gray R, Griffin J, Burstein P, Insel J, Scarlett J, Olefsky J (1981) Receptor and postreceptor defects contribute to the insulin resistance of noninsulin-dependent diabetes mellitus. J Clin Invest 68:957–969
Kriska AM, Bennett PH (1991) An epidemiological perspective of the relationship between physical activity and NIDDM: from activity assessment to intervention. Diabetes Metab Rev 8:355–372
Kusari J, Verma US, Buse JB, Henry RR, Olefsky JM (1991) Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. J Clin Invest 88:1323–1330
Laakso M, Edelman SV, Hoit B, Brechtel G, Baron AD (1992) Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 41: 1076–1083
Leahy JL (1990) Natural history of B-cell dysfunction in NIDDM. Diabetes Care 13:992–1010
Leahy JL, Bonner-Weir S, Weir GC (1992) B-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 15:442–455
Lefèbvre PJ (1991) Diabetes. Abnormal secretion of glucagon. In: Samols E (ed) The endocrine pancreas. Raven, New York, pp 191–205
Lefèbvre PJ (1993) Syndrome X. Diab Nutr Metab 6:61–65
Lefèbvre PJ, Scheen AJ (1992) Management of non-insulin-dependent diabetes mellitus. Drugs 44 [Suppl 3]:29–38
Lefèbvre PJ, Paolisso G, Scheen AJ, Henquin JC (1987) Pulsatility of insulin and glucagon release: Physiological significance and pharmacological implications. Diabetologia 30:443–452
Lefèbvre PJ, Paolisso G, Scheen A (1991) The role of glucagon in non-insulin-dependent (type 2) diabetes mellitus. In: Sakamoto N, Angel A, Hotta H (eds) New directions in research and clinical works for obesity and diabetes mellitus. Excerpta Medica, Amsterdam, pp 25–29
Lefèbvre PJ, Scheen AJ, Paolisso G, Giugliano D (1992) Opioid peptides and carbohydrate metabolism. In: Negri M, Lotti G, Grossman A (eds) Clinical perspectives of endogenous opioids production. Wiley, London, pp 255–273
Lefèbvre PJ, Paolisso G, Scheen AJ (1994) Magnésium et métabolisme glucidique. Thérapie 49:1–7
Lillioja S, Young AA, Cutler CL, Ivy JL, Abbott GH, Zawadzki JK, Yki-Jarvinen H, Christin L, Secomb TW, Bogardus C (1987) Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80:415–424
Lillioja S, Bogardus C (1988) Obesity and insulin resistance: lessons learned from the Pima indians. Diabetes Metab Rev 4:517–540
Malaisse WJ (1988) Possible sites for deficient glucose recognition in islet cells. In: Lefèbvre PJ, Pipeleers DG (eds) The pathology of the endocrine pancreas in diabetes. Springer, Berlin Heidelberg New York, pp 219–232
Mandarino LJ (1989) Regulation of skeletal muscle pyruvate dehydrogenase and glycogen synthase in man. Diabetes Metab Rev 5:475–486
Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925–929
Matschinsky FM (1990) Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes 39:647–652
Matschinsky F, Liang Y, Kesavan P, Wang L, Froguel Ph, Velho G, Cohen D, Permutt MA, Tanizawa Y, Jetton TL, Niswender K, Magnuson MA (1993) Glucokinase as pancreatic B cell glucose sensor and diabetes gene. J Clin Invest 92:2092–2098
Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22–29
Moller DE (1993) Insulin resistance. Wiley, Chichester
Moller DE, Flier JS (1991) Insulin resistance. Mechanisms, syndromes, and implications. N Engl J Med 325:938–948
O’Dea K (1992) Obesity and diabetes in “the land of milk and honey” . Diabetes Metab Rev 8:373–388
Olefsky JM (1976) The insulin receptor: its role in insulin resistance in obesity and diabetes. Diabetes 25:1154–1165
Olefsky JM, Garvey WT, Henry RR, Brillon D, Matthaei S, Freidenberg GR (1988) Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. Am J Med 85 [Suppl 5A]: 86–105
O’Rahilly SP, Nugent Z, Rudenski AS, Hosker JP, Burnett MA, Darling P, Turner RC (1986) Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet II: 360–363
O’Rahilly S, Turner RC, Matthews DR (1988) Impaired pulsatile secretion of insulin in relatives of patients with non-insulin dependent diabetes. N Engl J Med 318:1225–1230
Paolisso G, Sgambato S, Giugliano D, Torella R, Varricchio M, Scheen AJ, D’Onofrio F, Lefèbvre PJ (1988) Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31:910–915
Paolisso G, Scheen AJ, D’Onofrio F, Lefèbvre PJ (1990) Magnesium and glucose homeostasis. Diabetologia 33:511–514
Pedersen O (1989) The impact of obesity on the pathogenesis of non-insulin-dependent diabetes mellitus: a review of current hypotheses. Diabetes Metab Rev 5:495–509
Permutt MA, Elbein SC (1990) Insulin gene in diabetes: analysis through RFLP. Diabetes Care 13:364–372
Permutt MA, Chiu KC, Tanizawa Y (1992) Glucokinase and NIDDM: a candidate gene that paid off. Diabetes 41:1367–1372
Polonsky K, Frank B, Pugh W, Addis A, Karrison T, Meier P, Tager H, Rubenstein A (1986a) The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Diabetes 35:379–386
Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B (1986b) Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77:98–105
Polonsky KS, Given BD, Hirsch L, Shapiro EJ, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E (1988a) Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81:435–441
Polonsky KS, Given BD, Hirsch LJ, Tillil H, Shapiro ET (1988b) Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318:1231–1239
Porte D Jr (1991) B-cells in type II diabetes mellitus. Diabetes 40:166–180
Porte D Jr, Kahn SE (1989) Hyperproinsulinemia and amyloid in NIDDM — clues to etiology of islet B-cell dysfunction? Diabetes 38:1333–1336
Rahier J(1988) The diabetic pancreas: a pathologist’s view. In: Lefèbvre PJ, Pipeleers DG (eds) The pathology of the endocrine pancreas in diabetes. Springer, Berlin Heidelberg New York, pp 17–40
Randle PJ (1993) Glucokinase and candidate genes for Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:269–275
Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–789
Rasmussen H, Zawalich KC, Ganesan S, Calle R, Zawalich WS (1990) Physiology and pathophysiology of insulin secretion. Diabetes Care 13:655–666
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595–1607
Reaven GM (1990) Non-insulin-dependent diabetes (NIDDM): speculations on etiology. In Alberti KGMM, Krall LP (eds) The diabetes annual/5. Elsevier, Amsterdam, pp 51–71
Robertson RP (1989) Type II diabetes, glucose “non-sense”, and islet desensitization. Diabetes 38:1501–1505
Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care 13:610–630.
Rudenski AS, Matthews DR, Levy JC, Turner RC (1991) Understanding “insulin resistance”: both glucose resistance and insulin resistance are required to model human diabetes. Metabolism 40:908–917
Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH (1991) A two-step model for development of non-insulin-dependent diabetes. Am J Med 90:229–235
Saltiel AR (1990) Second messengers of insulin action. Diabetes Care 13:244–256
Schalin-Jantti C, Harkonen M, Groop LC (1992) Impaired activation of glycogen synthase activity in skeletal muscle from obese patients with and without Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:239–245
Scheen AJ (1992) From obesity to type 2 diabetes. Acta Clin Belg 47 [Suppl 14]: 30–36
Scheen AJ, Lefèbvre PJ (1992) Assessment of insulin sensitivity in vivo. Application to the study of type 2 diabetes. Horm Res 38:19–27
Scheen AJ, Lefèbvre PJ (1993a) De l’obésité au diabète ou de l’insulino-résistance au déficit insulino-sécrétoire. Rev Franç Endocrinol Clin 34:297–310
Scheen AJ, Lefèbvre PJ (1993b) Pharmacological treatment for the obese diabetic patient. Diabete Metab 19:547–559
Scheen AJ, Nemery A, Luyckx AS, Lefèbvre PJ (1986) Etiologie et Physiopathologie des diabètes sucrés. Encycl Méd Chir. Paris, Glandes-Nutrition, 10366 C10
Scheen AJ, Paquot N, Lefèbvre PJ (1991) La cellule B dans le diabète de type II: coupable ou victime? In: Journées Annuelles de Diabétologie de l’Hôtel-Dieu. Flammarion Médecine-Sciences, Paris, pp 153–169
Scheen AJ, Castillo M, Paolisso G, Jandrain B, Lefèbvre PJ (1992a) Normal feedback inhibition of insulin secretion by insulin but reduced metabolic clearance rate of the hormone in obese subjects. In: Ailhaud G, Guy-Grand B, Lafontan M, Ricquier D (eds) Obesity in Europe 91. Libbey, London, pp 201–205
Scheen AJ, Paolisso G, Castillo M, Jandrain B, Paquot N, Lefèbvre PJ (1992b) Insulin secretion and action in various populations with type 2 (non-insulin-dependent) diabetes mellitus (Abstract). Diabetologia 35 [Suppl 1]: A87
Scheen AJ, Paquot N, Castillo MJ, Lefèbvre PJ (1994) How to measure insulin action. Diabetes Metab Rev 10:151–188
Serjeantson SW, Zimmet P (1991) Genetics of non-insulin dependent diabetes mellitus in 1990. Bailliere’s Clin Endocrinol Metab 5:477–493
Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223–228
Songer TJ (1992) The economic costs of NIDDM. Diabetes Metab Rev 8:389–404
Steiner DF, Tager HS, Chan SJ, Nanjo T, Sanke T, Rubenstein AH (1990) Lessons learned from molecular biology of insulin-gene mutations. Diabetes Care 13: 600–607
Sturis J, Polonsky KS, Shapiro ET, Blackman JD, O’Meara NM, Van Cauter E (1992) Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 35:681–689
Temple RC, Clark PMS, Nagi DK, Schneider AE, Yudkin JS, Hales CN (1990) Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol (Oxf) 32:689–693
Temple RC, Clark PMS, Hales CN (1992) Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabetic Med 9:503–512
Thorens B, Waeber G (1993) Glucagon-like peptide-1 and the control of insulin secretion in the normal state and in NIDDM. Diabetes 42:1219–1225
Thornburn AW, Gumbiner B, Bulacan F, Brechtel G, Henry RR (1991) Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest 87:489–495
Turner RC, Matthews DR, Clark A, O’Rahilly S, Rudenski AS, Levy J (1988) Pathogenesis of NIDDM — a disease of deficient insulin secretion. Bailliere’s Clin Endocrinol Metab 2:327–342
Unger RH (1991) Diabetic hyperglycemia: link to impaired glucose transport in pancreatic B-cells. Science 251:1200–1205
Unger RH, Grundy S (1985) Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28:119–121
Vaag A, Henriksen JE, Beck-Nielsen H (1992) Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782–788
Vadheim CM, Rotter JI (1992) Genetics of diabetes mellitus. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds) International textbook of diabetes mellitus. Wiley, Chichester, pp 31–98
Vague J, Vague Ph (1988) Obesity and diabetes. In: Alberti KGMM, Krall LP (eds) The diabetes annual/4. Elsevier Science, Amsterdam, pp 311–338
Velho G, Froguel Ph, Clément K, Pueyo ME, Rakotoambinina B, Zouali H, Passa Ph, Cohen D, Robert JJ (1992) Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet 340:444–448
Vestergaard H, Bjorbaek C, Andersen PH, Bak JF, Pedersen O (1991) Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes 40:1740–1745
Ward WK, Beard JC, Porte D Jr (1986) Clinical aspects of islet B-cell function in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 2:297–313
Westermark P, Johnson KH, O’Brien TD, Betsholtz C (1992) Islet amyloid polypeptide — a novel controversy in diabetes research. Diabetologia 35:297–303
Wolffenbuttel BHR, Van Haeften TW (1993) Non-insulin dependent diabetes mellitus: defects in insulin secretion. Eur J Clin Invest 23:69–79
Yalow RS, Berson SA (1960) Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determination by a new sensitive immunoasssay technique. Diabetes 9:254–260
Yki-Järvinen H (1992) Glucose toxicity. Endocr Metab Rev 15:415–431
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scheen, A.J., Lefèbvre, P.J. (1996). Pathophysiology of Type 2 Diabetes Mellitus. In: Kuhlmann, J., Puls, W. (eds) Oral Antidiabetics. Handbook of Experimental Pharmacology, vol 119. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09127-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-662-09127-2_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-62456-1
Online ISBN: 978-3-662-09127-2
eBook Packages: Springer Book Archive